Application of a standardized coextractive cleanup procedure to routine high-performance liquid chromatography assays of teicoplanin and ganciclovir in plasma.

[1]  M. Kazatchkine,et al.  Low plasma concentrations achieved with conventional schedules of administration of ganciclovir in patients with AIDS. , 1996, The Journal of infectious diseases.

[2]  A. MacGowan,et al.  Assay of serum teicoplanin concentrations in clinical specimens: a comparison of isocratic high performance liquid chromatography with polarisation fluoroimmunoassay and bioassay. , 1994, The Journal of antimicrobial chemotherapy.

[3]  M. Whitby,et al.  Evaluation of a novel fluorescence polarization immunoassay for teicoplanin , 1993, Antimicrobial Agents and Chemotherapy.

[4]  R. Boulieu,et al.  Pharmacokinetics of Ganciclovir in Heart Transplant Patients Undergoing Continuous Venovenous Hemodialysis , 1993, Therapeutic drug monitoring.

[5]  W. S. St. Peter,et al.  Teicoplanin measurement in patients with renal failure: comparison of fluorescence polarization immunoassay, microbiological assay, and high-performance liquid chromatographic assay. , 1991, Therapeutic drug monitoring.

[6]  B. Joos,et al.  Determination of teicoplanin concentrations in serum by high-pressure liquid chromatography , 1987, Antimicrobial Agents and Chemotherapy.

[7]  J. Levy,et al.  High pressure liquid chromatographic quantitation of teicoplanin in human serum. , 1987, The Journal of antimicrobial chemotherapy.

[8]  S. Tadepalli,et al.  A competitive enzyme-linked immunosorbent assay to quantitate acyclovir and BW B759U in human plasma and urine , 1986, Antimicrobial Agents and Chemotherapy.

[9]  P. Chossegros,et al.  Pharmacokinetics of ganciclovir in a patient undergoing chronic haemodialysis , 2004, European Journal of Clinical Pharmacology.

[10]  W. Bennett,et al.  Pharmacokinetics of ganciclovir in a patient undergoing hemodialysis. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.